FDA: Farewell To 510(k) Review For 30 Types Of Low-Risk Diagnostic Tests
This article was originally published in The Gray Sheet
Executive Summary
FDA plans to exempt 30 types of diagnostic tests and radiology accessories from 510(k) review in one fell swoop, citing well-established safety and effectiveness profiles for the products.
You may also be interested in...
FDA Claims Short-Term Success For Pre-Market Device Reforms
With many of its 510(k) and science reforms at least partially implemented, CDRH says it is seeing tangible, positive results. The device center cites a turnaround on multiple measures of review performance following the lows of 2010.
Regulatory News In Brief
FDA's device center issues a significant draft guidance on the 510(k) program, plus a draft on appeals processes open to sponsors. More end-of-the-year regulatory developments.
FDA Dx Office Plans Pilot 510(k) ‘Triage’ Program For Early 2012
FDA’s diagnostics office will begin a pilot program in early 2012 to triage its review of 510(k) submissions based on product risk and application quality.